Mark Flather | Vice President, Investor Relations |
Shawn Singh | Chief Executive Officer |
Jerry Dotson | Chief Financial Officer |
Mark Smith | Chief Medical Officer |
Andrew Tsai | Jefferies |
Greetings, and welcome to the VistaGen Therapeutics First Quarter 2022 Results Conference Call.
During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. [Operator Instructions].
As a reminder, this conference is being recorded today, Thursday, August 12, 2021.